Full Papers
The role of a functional variant of TYK2 in vasculitides and infections
L. Ortiz-Fernández1, R. López-Mejias2, F.D. Carmona3, A.L. Castaño-Nuñez4, P.A. Lyons5, A. Caruz6, M.F. Gónzalez-Escribano7, K.G. Smith8, M.A. González-Gay9, J. Martin10
- Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. lurortiz.fernandez@gmail.com
- Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
- Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Spain.
- Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, Spain.
- Departments of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
- Immunogenetics Unit, Department of Experimental Biology, University of Jaén, Spain.
- Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, Spain.
- Departments of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
- Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
- Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. javiermartin@ipb.csic.es
on behalf of the Spanish GCA Study Group, IgAV Study Group, AAV Study Group and HIV Study Group
CER12499
2020 Vol.38, N°5
PI 0949, PF 0955
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 32167874 [PubMed]
Received: 12/06/2019
Accepted : 04/11/2019
In Press: 10/03/2020
Published: 02/10/2020
Abstract
OBJECTIVES:
The TYK2 gene encodes a tyrosin kinase which is involved in multiple immune functions. A functional variant of this gene has been identified to play a protective role in multiple autoimmune diseases. The goal of this study was to evaluate the involvement of this variant of TYK2 in vasculitides [giant cell arteritis (GCA), ANCA-associated vasculitis (AAV) and IgA vasculitis (IgAV)] and viral infections [hepatitis C virus (HCV) and human immunodeficiency virus type I (HIV-1)].
METHODS:
The study sample was composed of 13,745 European individuals. The genotyping was performed by Immunochip and TaqMan 5’ allele discrimination assays and the allele frequencies were compared using PLINK.
RESULTS:
Although the results obtained did not reach the genome-wide level of significance, p-values at nominal significance were observed, suggesting that the TYK2 variant provides protection against two vasculitides: GCA (p=5.94E-3; OR (95%CI) = 0.56 (0.37–0.85) and AAV (p=6.79E-3; OR (95%CI) = 0.65 (0.47–0.89). However, this variant was not found to be associated with IgAV. No evidence was gained that the TYK2 variant confers susceptibility to HCV and HIV-1 infection.
CONCLUSIONS:
This is the first study to propose the association between the TYK2 and both GCA and AAV. Our findings also suggest that TYK2 does not play a relevant role in IgAV or in susceptibility to HCV and HVI-1.